MedPath

AudioCure Pharma GmbH

AudioCure Pharma GmbH logo
🇩🇪Germany
Ownership
Holding
Established
2010-01-01
Employees
1
Market Cap
-
Website
http://www.audiocure.de
hearingreview.com
·

AC102 Shows Promise as Treatment for Sudden Hearing Loss

A MedUni Vienna-led study on AC102 shows promise for treating acute sudden hearing loss by protecting inner ear structures and reducing inflammation. Phase I safety trials are successful, and Phase II efficacy trials are underway. If effective, AC102 could be an alternative to cortisone.
© Copyright 2025. All Rights Reserved by MedPath